DISCLAIMER:
Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.
Keywords: radiation risk
| MO-J-BRA-0 | Managing Implanted Devices S Lim1*, S Kry2*, C Shi3*, M Chan4*, (1) Memorial Sloan-Kettering Cancer Center, Somerset, NJ, (2) The University of Texas MD Anderson Cancer Center, Houston, TX, (3) New York Proton Center, Edgewater, NJ, (4) Memorial Sloan Kettering Cancer Center, Basking Ridge, NJ |
| MO-J-BRA-1 | Dosimetric Concerns of Post-Mastectomy Tissue Expanders During External Beam Radiation Therapy S Lim1*, S Kry2*, C Shi3*, M Chan4*, (1) Memorial Sloan-Kettering Cancer Center, Somerset, NJ, (2) The University of Texas MD Anderson Cancer Center, Houston, TX, (3) New York Proton Center, Edgewater, NJ, (4) Memorial Sloan Kettering Cancer Center, Basking Ridge, NJ |
| MO-J-BRA-2 | Clinical Management of Cardiac Implantable Electronic Device (CIED) Patients S Lim1*, S Kry2*, C Shi3*, M Chan4*, (1) Memorial Sloan-Kettering Cancer Center, Somerset, NJ, (2) The University of Texas MD Anderson Cancer Center, Houston, TX, (3) New York Proton Center, Edgewater, NJ, (4) Memorial Sloan Kettering Cancer Center, Basking Ridge, NJ |
| MO-J-BRA-3 | Clinical Practices of Managing Implantable Medical Devices for Proton Therapy S Lim1*, S Kry2*, C Shi3*, M Chan4*, (1) Memorial Sloan-Kettering Cancer Center, Somerset, NJ, (2) The University of Texas MD Anderson Cancer Center, Houston, TX, (3) New York Proton Center, Edgewater, NJ, (4) Memorial Sloan Kettering Cancer Center, Basking Ridge, NJ |
| MO-J-BRA-4 | A Review of Managing Commonly Seen Implanted Devices for Radiotherapy Patients S Lim1*, S Kry2*, C Shi3*, M Chan4*, (1) Memorial Sloan-Kettering Cancer Center, Somerset, NJ, (2) The University of Texas MD Anderson Cancer Center, Houston, TX, (3) New York Proton Center, Edgewater, NJ, (4) Memorial Sloan Kettering Cancer Center, Basking Ridge, NJ |
| MO-J-BRA-5 | Q & A S Lim1*, S Kry2*, C Shi3*, M Chan4*, (1) Memorial Sloan-Kettering Cancer Center, Somerset, NJ, (2) The University of Texas MD Anderson Cancer Center, Houston, TX, (3) New York Proton Center, Edgewater, NJ, (4) Memorial Sloan Kettering Cancer Center, Basking Ridge, NJ |
| PO-GePV-M-349 | Quantitative Evaluation of Radiodermatitis Following Whole-Breast Radiotherapy with Various Color Space Models: A Feasibility Study S Park1*, J Kim2, C Choi2, J Park2, J Kim2, (1) Veterans Health Service Medical Center, Seoul, KR, (2) Seoul National University Hospital, Seoul, KR |
| PO-GePV-T-94 | Investigation of KV Imaging Dose in Accelerated Partial Breast Irradiation (APBI) Y Song1*, X Zhai2, Y Liang3, B Mueller4, D Guttmann5, D Roth O'Brien6, L Braunstein7, (1) Memorial Sloan Kettering Cancer Center, Bergen, NJ,(2) Memorial Sloan Kettering Cancer Center, Bergen, NJ,(3) Memorial Sloan Kettering Cancer Center, Bergen, NJ,(4) Memorial Sloan Kettering Cancer Center, Bergen, NJ,(5) Memorial Sloan Kettering Cancer Center, Bergen, NJ,(6) Memorial Sloan Kettering Cancer Center, Bergen, NJ,(7) Memorial Sloan-Kettering Cancer Center, New York, NY |
| PO-GePV-T-207 | Radiation Dose Tolerance of a Medtronic Deep Brain Stimulator Based On OSLD Measurement M Klash1*, S Klash2, E Mcclelland3, L Brennan4, J Grubic5, (1) KSEC, Belmont, Ohio, (2) VAPHS, Pittsburgh, PA, (3) VAPHS, Pittsburgh, PA, (4) VAPHS, Pittsburgh, PA, (5) VAPHS, Pittsburgh, PA |
| PO-GePV-T-212 | Radiation Dose Tolerance Assessment of the Zio Heart Monitor S Klash1*, L Brennan2, J Graham3, (1) VAPHS, Pittsburgh, PA, (2) VAPHS, Pittsburgh, PA, (3) VAPHS, Pittsburgh, PA |
| TU-D1030-IePD-F2-3 | Segmentation of the Left Anterior Descending Coronary Artery Using Curvature-Guided Deep Learning for Lung Cancer Patients Treated with Radiotherapy Y Yue*, A Curtis, S Ng, K Huang, T Lautenschlaeger, Indiana University- School of Medicine, Indianapolis, IN |
| WE-FG-207-0 | Gonadal & Fetal Shielding Updates J Elee1*, Y Thakur2*, Q Moore3*, R Milman4*, (1) LA Dept of Environmental Qual, West Monroe, LA, (2) Vancouver Coastal Health Authority, Vancouver, BC, CA, (3) Mercy College of Ohio, Toledo, OH, (4) University of Colorado School of Medicine, Denver, CO |
| WE-FG-207-1 | Regulatory Implications of Changes in Patient Shielding Practices J Elee1*, Y Thakur2*, Q Moore3*, R Milman4*, (1) LA Dept of Environmental Qual, West Monroe, LA, (2) Vancouver Coastal Health Authority, Vancouver, BC, CA, (3) Mercy College of Ohio, Toledo, OH, (4) University of Colorado School of Medicine, Denver, CO |
| WE-FG-207-2 | Implementing Change in Patient Shielding Practices J Elee1*, Y Thakur2*, Q Moore3*, R Milman4*, (1) LA Dept of Environmental Qual, West Monroe, LA, (2) Vancouver Coastal Health Authority, Vancouver, BC, CA, (3) Mercy College of Ohio, Toledo, OH, (4) University of Colorado School of Medicine, Denver, CO |
| WE-FG-207-3 | A Technologist's View of Patient Shielding J Elee1*, Y Thakur2*, Q Moore3*, R Milman4*, (1) LA Dept of Environmental Qual, West Monroe, LA, (2) Vancouver Coastal Health Authority, Vancouver, BC, CA, (3) Mercy College of Ohio, Toledo, OH, (4) University of Colorado School of Medicine, Denver, CO |
| WE-FG-207-4 | Patient Shielding: What's Next? J Elee1*, Y Thakur2*, Q Moore3*, R Milman4*, (1) LA Dept of Environmental Qual, West Monroe, LA, (2) Vancouver Coastal Health Authority, Vancouver, BC, CA, (3) Mercy College of Ohio, Toledo, OH, (4) University of Colorado School of Medicine, Denver, CO |
| WE-FG-207-5 | Q & A J Elee1*, Y Thakur2*, Q Moore3*, R Milman4*, (1) LA Dept of Environmental Qual, West Monroe, LA, (2) Vancouver Coastal Health Authority, Vancouver, BC, CA, (3) Mercy College of Ohio, Toledo, OH, (4) University of Colorado School of Medicine, Denver, CO |